NCT05028725View on ClinicalTrials.gov

Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Esophageal Squamous Cell CarcinomaEsophageal Squamous Dysplasia
Interventions
DEVICE

EsophaCap Sponge

Non-invasive strategy to sample esophageal tissue

PROCEDURE

Chromoendoscopy

Lugol's iodine chromoendoscopy is a technique that is used to identify mucosal abnormalities of the esophagus

DEVICE

EsoCAN assay

Biomarker Test

Trial Locations (2)

Unknown

RECRUITING

Muhimbili National Hospital (MNH), Dar es Salaam

RECRUITING

Muhimbili National Hospital (MNH), Dar es Salaam

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Johns Hopkins University

OTHER

collaborator

Muhimbili University of Health and Allied Sciences

OTHER

collaborator

CapNostics, LLC

UNKNOWN

lead

University of California, San Francisco

OTHER